文献速递产科母胎医学

双胎妊娠晚期早产风险患者产前皮质类固醇与新生儿结局

Antenatal Corticosteroids and Neonatal Outcomes Among Patients With Twin Gestations at Risk for Late Preterm Birth.
PubMed 文献 · Obstet Gynecol · 2025-11-07

本研究为多中心回顾性队列研究,纳入2013-2022年34 0/7至36 6/7周有早产风险的双胎妊娠患者,比较产前皮质类固醇暴露组与未暴露组的新生儿呼吸系统疾病复合结局。结果显示两组复合结局无差异(23.4% vs 20.4%,P=.40,校正RR 1.00,95%CI 0.71-1.42),但暴露组补充氧和机械通气风险较低,因低血糖入住NICU风险较高。

要点

  • 双胎晚期早产风险患者中,产前皮质类固醇未降低新生儿呼吸系统疾病复合结局风险。
  • 暴露组补充氧(0.6% vs 3.5%)和机械通气(0.6% vs 3.2%)风险较低。
  • 暴露组因低血糖作为唯一NICU入住指征的风险较高(10.3% vs 5.2%)。

核心结论

  • 在有晚期早产风险的双胎妊娠患者中,产前皮质类固醇使用与总体呼吸系统疾病减少无关,但与补充氧和机械通气需求风险降低相关,且因低血糖入住NICU风险较高。

研究设计与样本

  • 多中心回顾性队列研究,纳入2013-2022年大型城市健康网络内34 0/7至36 6/7周有早产风险的双胎妊娠患者。
  • 共纳入366例双胎妊娠和722例患者-新生儿配对,暴露组162例妊娠(321例新生儿),未暴露组204例妊娠(401例新生儿)。

主要发现

  • 呼吸系统疾病复合结局在暴露组为23.4%,未暴露组为20.4%(P=.40,校正RR 1.00,95%CI 0.71-1.42)。
  • CPAP使用率暴露组21.2% vs 未暴露组18.5%(P=.41,校正RR 1.05,95%CI 0.73-1.53)。
  • 高流量鼻导管使用率暴露组6.2% vs 未暴露组2.2%(P=.02,RR 2.77,95%CI 1.16-6.66)。
  • 补充氧需求暴露组0.6% vs 未暴露组3.5%(P=.02,RR 0.18,95%CI 0.04-0.79);机械通气暴露组0.6% vs 未暴露组3.2%(P=.03,RR 0.19,95%CI 0.04-0.87)。
  • 低血糖发生率暴露组44.2% vs 未暴露组41.7%(P=.57,校正RR 0.99,95%CI 0.82-1.19);低血糖作为唯一NICU入住指征暴露组10.3% vs 未暴露组5.2%(P=.03,RR 1.96,95%CI 1.07-3.59)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether administration of antenatal corticosteroids to patients with twin gestations at risk for late preterm delivery is associated with reduced risk for neonatal respiratory morbidity compared with unexposed twins. METHODS: This was a multicenter, retrospective cohort study in a large, urban health network (2013-2022) of patients with twin gestations at risk for preterm delivery between 34 0/7 and 36 6/7 weeks of gestation. Patients were excluded if they received antenatal corticosteroids before 34 weeks of gestation or had pregestational diabetes, single-twin death before 34 weeks, or oral steroid exposure during pregnancy. Neonates were excluded if they had major congenital anomalies. The primary outcome was a composite of neonatal respiratory morbidity requiring respiratory support within 72 hours of birth, including continuous positive airway pressure (CPAP) or high-flow nasal cannula for 2 hours or more, supplemental oxygen of 30% for 2 hours or more, extracorporeal membrane oxygenation, mechanical ventilation, and fetal or neonatal death. Secondary outcomes included neonatal hypoglycemia and indications for neonatal intensive care unit (NICU) admission. Adjusted and unadjusted relative risks with 95% CIs were calculated. RESULTS: During the study period, 366 twin gestations and 722 patient-neonate dyads were included: 162 gestations (321 neonates) in the exposed group and 204 (401 neonates) in the unexposed group. There was no difference in the composite outcome of respiratory morbidity in those exposed to antenatal corticosteroids (23.4% vs 20.4%, P =.40, adjusted relative risk [RR] 1.00, 95% CI, 0.71-1.42). The composite was driven mostly by rates of CPAP use (21.2% vs 18.5%, P =.41, adjusted RR 1.05, 95% CI, 0.73-1.53) and high-flow nasal cannula use (6.2% vs 2.2%, P =.02, RR 2.77, 95% CI, 1.16-6.66). Antenatal corticosteroid exposure was associated with a lower risk of need for supplemental oxygen (0.6% vs 3.5%, P =.02, RR 0.18, 95% CI, 0.04-0.79) and mechanical ventilation (0.6% vs 3.2%, P =.03, RR 0.19, 95% CI, 0.04-0.87). Although antenatal corticosteroids exposure was not associated with higher rates of hypoglycemia (44.2% vs 41.7%, P =.57, adjusted RR 0.99, 95% CI, 0.82-1.19), exposure was associated with a higher risk of having hypoglycemia as the only indication for NICU admission (10.3% vs 5.2%, P =.03, RR 1.96, 95% CI, 1.07-3.59). CONCLUSION: In a large, multicenter, network-wide retrospective cohort study of patients with twin gestations at risk for late preterm birth, antenatal corticosteroid use was not associated with a decrease in overall respiratory morbidity but was associated with a decreased risk of need for supplemental oxygen and mechanical ventilation, as well as a higher risk of NICU admission for hypoglycemia. These results underscore the ongoing need to elucidate the risks and benefits of late preterm antenatal corticosteroids for patients with twin gestations at risk for late preterm birth.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Berger DS, Abbas DS, Marty LN, et al. Antenatal Corticosteroids and Neonatal Outcomes Among Patients With Twin Gestations at Risk for Late Preterm Birth. Obstet Gynecol. 2025. PMID: 41197128. doi:10.1097/AOG.0000000000006114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。